Point72 Asset Management’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-847,558
| Closed | -$16.8M | – | 1276 |
|
|
2025
Q1 | $16.8M | Buy |
847,558
+635,232
| +299% | +$12.6M | 0.04% | 416 |
|
|
2024
Q4 | $3.64M | Buy |
212,326
+101,315
| +91% | +$1.74M | 0.01% | 718 |
|
|
2024
Q3 | $2.22M | Buy |
111,011
+7,556
| +7% | +$151K | 0.01% | 733 |
|
|
2024
Q2 | $1.16M | Buy |
+103,455
| New | +$1.16M | ﹤0.01% | 795 |
|
|
2024
Q1 | – | Sell |
-244,513
| Closed | -$1.11M | – | 1396 |
|
|
2023
Q4 | $1.11M | Buy |
+244,513
| New | +$1.11M | ﹤0.01% | 910 |
|
|
2023
Q2 | – | Sell |
-1,934,576
| Closed | -$6.4M | – | 1585 |
|
|
2023
Q1 | $6.4M | Sell |
1,934,576
-56,524
| -3% | -$187K | 0.02% | 605 |
|
|
2022
Q4 | $7.73M | Buy |
+1,991,100
| New | +$7.73M | 0.03% | 561 |
|
|
2020
Q2 | – | Sell |
-250,000
| Closed | -$720K | – | 744 |
|
|
2020
Q1 | $720K | Buy |
+250,000
| New | +$720K | 0.01% | 604 |
|